Figure. Participant Flow Diagram.

^aReceived treatment for schizophrenia or another psychotic disorder within past year.

^bFor stroke, myocardial infarction, congestive heart failure, or diabetes.

^cData collected through 52 weeks.

^dDid not complete the week 52 telephone assessment. These data include participants who withdrew from the study.

^eFor the primary outcome of self-reported 7-day point prevalence abstinence (biochemically confirmed as exhaled carbon monoxide level ≤5 ppm) at 52 weeks after target quit day, the analyses used the full sample randomized to the treatment groups (N = 1251) and assumed that missing observations reflected current smoking.